Production and nonclinical evaluation of an autologous iPSC–derived platelet product for the iPLAT1 clinical trial
Sign Up to like & getrecommendations! Published in 2022 at "Blood Advances"
DOI: 10.1182/bloodadvances.2022008512
Abstract: Key Points • GMP-based iPSC-platelet production using imMKCL master cells from an aplastic anemia patient with alloimmune transfusion refractoriness.• Extensive nonclinical evaluation confirmed the safety, quality, and efficacy of the patient iPSC-platelet product. read more here.
Keywords: nonclinical evaluation; production nonclinical; platelet product;